Modeling vaccine-induced immunotherapy: treatment scheduling and robustness with virtual mice cohorts
P. Bhatt, M. Kambara, S. Pilon-Thomas, K. A. Rejniak, I. M. Chamseddine
Abstract
Therapeutic vaccines are used to boost patients immune system activity by imposing signals that increase T cell proliferation or infiltration. A large population of cytotoxic T cells may then be able to reduce tumor growth. We developed here a mathematical model of vaccine-induced immunotherapy and used it to test the vaccine frequency and doses that can reduce tumor burden. Since tumors are heterogeneous, we examined if the proposed treatments are robust; i.e, are successful for a wide range of tumors. This was assessed by constructing virtual mice cohorts. Together, the optimal and most robust treatment protocol was determined through mathematical modeling.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- From concept to clinic: mathematically informed immunotherapy
Rachel Walker, Heiko Enderling·Current Problems in CancerPeer-reviewed·Jan 1, 2016
- Optimizing the Efficacy of Vaccine-Induced Immunotherapy in Melanomas
Ibrahim M. Chamseddine, Manoj Kambara, … Katarzyna Anna Rejniak·Bulletin of Mathematical BiologyPeer-reviewed·May 28, 2025
- Addressing current challenges in cancer immunotherapy with mathematical and computational modeling
Anna Konstorum, Anthony T. Vella, … Reinhard Laubenbacher·Journal of The Royal Society InterfacePeer-reviewed·Jun 1, 2017
- Run for your life: an integrated virtual tissue platform for incorporating exercise oncology into immunotherapy
J. O. Aponte-Serrano, A. Hagar·bioRxiv·Sep 4, 2020
- A minimal model of T cell avidity may identify subtherapeutic vaccine schedules
A. Kumbhari, D. Rose, … P. S. Kim·bioRxiv·Dec 6, 2020
- The Goldilocks Window of Personalized Chemotherapy: An Immune Perspective
Derek S. Park, Mark Robertson-Tessi, … Alexander RA Anderson·bioRxiv·Dec 13, 2018